The information provided in this handout does not necessarily reflect the views of the University of Minnesota Medical School physicians and faculty. These materials are provided for informational purposes only and are in no way intended to take the place of the advice and recommendations of your personal health care provider. You use the information provided in these handouts at your own risk.There is not enough evidence to make definitive recommendations for PSA as a screening tool for men younger than 75 years. In depth discussion regarding patient’s definition of quality of life is necessary to address the potential risks and benefits of screening and potential disease. This includes both psychological effects of false positive test as ...
BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but...
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to scree...
Aims: The Göteborg randomized population-based prostate cancer screening trial is a prospective stud...
The information provided in this handout does not necessarily reflect the views of the University of...
The information provided in this handout does not necessarily reflect the views of the University of...
Prostate cancer is a devastating illness. Approximately28 000 American men will die of it this year ...
Context Prostate-specific antigen (PSA) testing increases prostate cancer diagnoses and reduces long...
PSA screening remains highly controversial due to several important disadvantages. More PSA is produ...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
The benefits of population-based prostate cancer screening are the detection of clinically important...
textabstractSince the first publication describing the identification of prostate-specific antigen (...
Prostate specific antigen (PSA) screening is an integral part of current screening for prostate canc...
Background:Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but ...
Disclosures of potential conflicts of interest may be found at the end of this article. The authors ...
Universal screening for prostate cancer (Pca) using prostate-specific antigen-based testing is not r...
BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but...
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to scree...
Aims: The Göteborg randomized population-based prostate cancer screening trial is a prospective stud...
The information provided in this handout does not necessarily reflect the views of the University of...
The information provided in this handout does not necessarily reflect the views of the University of...
Prostate cancer is a devastating illness. Approximately28 000 American men will die of it this year ...
Context Prostate-specific antigen (PSA) testing increases prostate cancer diagnoses and reduces long...
PSA screening remains highly controversial due to several important disadvantages. More PSA is produ...
What is the role of prostate-specific antigen (PSA) screening in prostate cancer? An expert panel pr...
The benefits of population-based prostate cancer screening are the detection of clinically important...
textabstractSince the first publication describing the identification of prostate-specific antigen (...
Prostate specific antigen (PSA) screening is an integral part of current screening for prostate canc...
Background:Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but ...
Disclosures of potential conflicts of interest may be found at the end of this article. The authors ...
Universal screening for prostate cancer (Pca) using prostate-specific antigen-based testing is not r...
BACKGROUND: Screening with prostate-specific antigen (PSA) can reduce prostate cancer mortality, but...
Objective To investigate the efficacy and safety of prostate-specific antigen (PSA) testing to scree...
Aims: The Göteborg randomized population-based prostate cancer screening trial is a prospective stud...